chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Magnetic resonance imaging head normal, Pain in jaw, Pyrexia, Visual impairment
Clinical narrative: She got her vaccine, on 5/12/22 she had the normal chills, fever, and then started having a headache on the left side, ear pain and pain in her left jaw. She woke up with no vision in her left eye.  Then it progressed to loss of vision in her right eye, no reading vision.  She ended up going to the ER that same day.  Her left eye vision recovered within an hour, her reading vision is still impaired.  On 5/28/22 she had worsening pain on the left side of her face, headaches requiring a hospital visit, and an overnight stay.  She was seen by a neurologist and placed on medication (Trileptal).  She still has the sensation of pain in the jaw and the ear, and intermittent headaches depending on what situation she is doing.  If she is thinking very hard or stressed the pain is worse.    She had a CT scan and an MRI of her brain, which did not show anything.  The neurologist said that there is potential nerve damage, trigeminal and occipital neuralgia.  She is to FU with him.  She saw the ophthalmologist first and he saw no findings and referred her to the ER, but she had just been to the ER.  The neurologist was from her hospital stay.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: date of death 05-03-22   His PUI forms note he was asx for covid at time of his + test  07-24-2021
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood immunoglobulin G decreased, Cardiac failure, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Dizziness
Clinical narrative: liver pain,  fever 101July 23-24, 2022 8:00 am foggy mind/lightheaded/dizzy/ July 23, 2022 8:00 am lower legs and toes convulsions July 24--28, 2022 severe heart failure July 26- present requiring 13 days hospitalization, treatment with IV diuretics, Lassix and increased dose , twice my normal oral lassie 80mg twice daily instead 40 twice daily, still elevated heart failure pulmonary edema, severe shortness of breath July 23-present August 30, 2022 pneumonia- treated with 5 days IV Rocephin July30-August 2, 2022 bilateral leg convulsions July 24-July 30, 2022 treated with Gabapentin, still not resolved
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electromyogram abnormal, Feeling abnormal, Hepatic pain, Immunodeficiency
Clinical narrative: liver pain,  fever 101July 23-24, 2022 8:00 am foggy mind/lightheaded/dizzy/ July 23, 2022 8:00 am lower legs and toes convulsions July 24--28, 2022 severe heart failure July 26- present requiring 13 days hospitalization, treatment with IV diuretics, Lassix and increased dose , twice my normal oral lassie 80mg twice daily instead 40 twice daily, still elevated heart failure pulmonary edema, severe shortness of breath July 23-present August 30, 2022 pneumonia- treated with 5 days IV Rocephin July30-August 2, 2022 bilateral leg convulsions July 24-July 30, 2022 treated with Gabapentin, still not resolved
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, Neuropathy peripheral, Pleural effusion, Pneumonia, Polyuria
Clinical narrative: liver pain,  fever 101July 23-24, 2022 8:00 am foggy mind/lightheaded/dizzy/ July 23, 2022 8:00 am lower legs and toes convulsions July 24--28, 2022 severe heart failure July 26- present requiring 13 days hospitalization, treatment with IV diuretics, Lassix and increased dose , twice my normal oral lassie 80mg twice daily instead 40 twice daily, still elevated heart failure pulmonary edema, severe shortness of breath July 23-present August 30, 2022 pneumonia- treated with 5 days IV Rocephin July30-August 2, 2022 bilateral leg convulsions July 24-July 30, 2022 treated with Gabapentin, still not resolved
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Prohormone brain natriuretic peptide, Pulmonary oedema, Pyrexia, Seizure
Clinical narrative: liver pain,  fever 101July 23-24, 2022 8:00 am foggy mind/lightheaded/dizzy/ July 23, 2022 8:00 am lower legs and toes convulsions July 24--28, 2022 severe heart failure July 26- present requiring 13 days hospitalization, treatment with IV diuretics, Lassix and increased dose , twice my normal oral lassie 80mg twice daily instead 40 twice daily, still elevated heart failure pulmonary edema, severe shortness of breath July 23-present August 30, 2022 pneumonia- treated with 5 days IV Rocephin July30-August 2, 2022 bilateral leg convulsions July 24-July 30, 2022 treated with Gabapentin, still not resolved
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Blood test normal, Cerebrovascular accident, Cognitive disorder, Computerised tomogram head normal
Clinical narrative: About 3 1/2 months after vaccination of dose 3, I started having a pretty intense headache and generally did not feel well. I was having insomnia. I went to the doctor in December 2021 and I was noted to have high blood pressure. They gave me an aspirin due to blood pressure being in stroke range. I was put on blood pressure medication and it did not lower my blood pressure. After 10 days, I was switched to a different blood pressure medication as well as a diuretic and these did not work well either. In January 2022, I was switched to a 3rd blood pressure medication (BYSTOLIC). Later in the month of January 2022, I had a spiking headache that was over my left eye. I lost my ability to speak and write. My cognitive ability was also affected and I was having difficulty texting and I knew I was having a stroke. I went to the doctors office but by that time I could speak but it was slow. I was also having problems walking. My blood pressure was really high. My doctors office complex is very large and so we did a CAT scan of my head which showed normal. I also had an MRI a few days later at the hospital and it showed I had no active bleeding but could not rule a stroke out. My doctor added a 2nd blood pressure medication (losartan). He told me my symptoms went on longer than a TIA. I started monitoring my blood pressure at home. In July 2022, I had another episode of a spiking headache over my left eye again but I could talk. I did have numbness down my left arm. I was aware of what was happening. I did see a lot of pretty colors in both eyes. I went back to my primary care doctors office and I saw a different doctor in my doctors practice and I had another CT scan of my head but it returned as normal results. I had another MRI a few days later and it showed that I did not have an active bleed. I was given a prescription for a diuretic as needed for elevated blood pressure but I do not like the way it makes me feel and is not really effective. I have subsequently had a lot of blood work done but this was not related to my symptoms. All came back normal. My headache has lessened in severity but has never gone away. I am still having problems controlling my blood pressure.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgraphia, Gait disturbance, Headache, Hypertension, Hypoaesthesia
Clinical narrative: About 3 1/2 months after vaccination of dose 3, I started having a pretty intense headache and generally did not feel well. I was having insomnia. I went to the doctor in December 2021 and I was noted to have high blood pressure. They gave me an aspirin due to blood pressure being in stroke range. I was put on blood pressure medication and it did not lower my blood pressure. After 10 days, I was switched to a different blood pressure medication as well as a diuretic and these did not work well either. In January 2022, I was switched to a 3rd blood pressure medication (BYSTOLIC). Later in the month of January 2022, I had a spiking headache that was over my left eye. I lost my ability to speak and write. My cognitive ability was also affected and I was having difficulty texting and I knew I was having a stroke. I went to the doctors office but by that time I could speak but it was slow. I was also having problems walking. My blood pressure was really high. My doctors office complex is very large and so we did a CAT scan of my head which showed normal. I also had an MRI a few days later at the hospital and it showed I had no active bleeding but could not rule a stroke out. My doctor added a 2nd blood pressure medication (losartan). He told me my symptoms went on longer than a TIA. I started monitoring my blood pressure at home. In July 2022, I had another episode of a spiking headache over my left eye again but I could talk. I did have numbness down my left arm. I was aware of what was happening. I did see a lot of pretty colors in both eyes. I went back to my primary care doctors office and I saw a different doctor in my doctors practice and I had another CT scan of my head but it returned as normal results. I had another MRI a few days later and it showed that I did not have an active bleed. I was given a prescription for a diuretic as needed for elevated blood pressure but I do not like the way it makes me feel and is not really effective. I have subsequently had a lot of blood work done but this was not related to my symptoms. All came back normal. My headache has lessened in severity but has never gone away. I am still having problems controlling my blood pressure.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Magnetic resonance imaging head normal, Malaise, Slow speech, Visual impairment
Clinical narrative: About 3 1/2 months after vaccination of dose 3, I started having a pretty intense headache and generally did not feel well. I was having insomnia. I went to the doctor in December 2021 and I was noted to have high blood pressure. They gave me an aspirin due to blood pressure being in stroke range. I was put on blood pressure medication and it did not lower my blood pressure. After 10 days, I was switched to a different blood pressure medication as well as a diuretic and these did not work well either. In January 2022, I was switched to a 3rd blood pressure medication (BYSTOLIC). Later in the month of January 2022, I had a spiking headache that was over my left eye. I lost my ability to speak and write. My cognitive ability was also affected and I was having difficulty texting and I knew I was having a stroke. I went to the doctors office but by that time I could speak but it was slow. I was also having problems walking. My blood pressure was really high. My doctors office complex is very large and so we did a CAT scan of my head which showed normal. I also had an MRI a few days later at the hospital and it showed I had no active bleeding but could not rule a stroke out. My doctor added a 2nd blood pressure medication (losartan). He told me my symptoms went on longer than a TIA. I started monitoring my blood pressure at home. In July 2022, I had another episode of a spiking headache over my left eye again but I could talk. I did have numbness down my left arm. I was aware of what was happening. I did see a lot of pretty colors in both eyes. I went back to my primary care doctors office and I saw a different doctor in my doctors practice and I had another CT scan of my head but it returned as normal results. I had another MRI a few days later and it showed that I did not have an active bleed. I was given a prescription for a diuretic as needed for elevated blood pressure but I do not like the way it makes me feel and is not really effective. I have subsequently had a lot of blood work done but this was not related to my symptoms. All came back normal. My headache has lessened in severity but has never gone away. I am still having problems controlling my blood pressure.
Age: 2.0
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Product preparation issue
Clinical narrative: Patient received DTaP-IPV- without Hib. Parent was called to re-due the vaccine per pharmacist recommendation .
Age: 34.0
Sex: M
Vaccine: MENB
Symptoms: Activated partial thromboplastin time, Atelectasis, Blood gases, Chest X-ray, Chest tube insertion
Clinical narrative: This 34 year-old male was involved in a sole vehicle helmeted motorcycle crash in which he suffered impact to his left side resulting in a grade V splenic laceration. Active splenic artery extravasation was managed with repeated arterial embolization by interventional radiology resulting in hemostasis but with large volume hemoperitoneum. Increasing pleural effusion with evidence of left hemothorax with adjacent atelectasis led to increasing oxygen requirements necessitating chest tube placement. In preparation for eventual discharge post-splenectomy vaccines were ordered and administered. Approximately 2 hours following administration, the patient became tachycardic with heart rate in the 170s and tachypneic to the 50s with a fall in oxygen saturation requiring O2 at up to 15 L/min. Severe rigors developed requiring treatment with meperidine and diphenhydramine. The patient was transferred to intensive care for ongoing management of hemothorax and video-assisted thoracoscopic surgery (VATS). Future vaccine administration to be managed by Allergy and Immunology.
Age: 34.0
Sex: M
Vaccine: MENB
Symptoms: Chills, Extravasation, Full blood count, Haemoperitoneum, Haemostasis
Clinical narrative: This 34 year-old male was involved in a sole vehicle helmeted motorcycle crash in which he suffered impact to his left side resulting in a grade V splenic laceration. Active splenic artery extravasation was managed with repeated arterial embolization by interventional radiology resulting in hemostasis but with large volume hemoperitoneum. Increasing pleural effusion with evidence of left hemothorax with adjacent atelectasis led to increasing oxygen requirements necessitating chest tube placement. In preparation for eventual discharge post-splenectomy vaccines were ordered and administered. Approximately 2 hours following administration, the patient became tachycardic with heart rate in the 170s and tachypneic to the 50s with a fall in oxygen saturation requiring O2 at up to 15 L/min. Severe rigors developed requiring treatment with meperidine and diphenhydramine. The patient was transferred to intensive care for ongoing management of hemothorax and video-assisted thoracoscopic surgery (VATS). Future vaccine administration to be managed by Allergy and Immunology.
Age: 34.0
Sex: M
Vaccine: MENB
Symptoms: Haemothorax, Intensive care, International normalised ratio, Interventional procedure, Metabolic function test
Clinical narrative: This 34 year-old male was involved in a sole vehicle helmeted motorcycle crash in which he suffered impact to his left side resulting in a grade V splenic laceration. Active splenic artery extravasation was managed with repeated arterial embolization by interventional radiology resulting in hemostasis but with large volume hemoperitoneum. Increasing pleural effusion with evidence of left hemothorax with adjacent atelectasis led to increasing oxygen requirements necessitating chest tube placement. In preparation for eventual discharge post-splenectomy vaccines were ordered and administered. Approximately 2 hours following administration, the patient became tachycardic with heart rate in the 170s and tachypneic to the 50s with a fall in oxygen saturation requiring O2 at up to 15 L/min. Severe rigors developed requiring treatment with meperidine and diphenhydramine. The patient was transferred to intensive care for ongoing management of hemothorax and video-assisted thoracoscopic surgery (VATS). Future vaccine administration to be managed by Allergy and Immunology.
Age: 34.0
Sex: M
Vaccine: MENB
Symptoms: Oxygen saturation decreased, Pleural effusion, Prothrombin time, Road traffic accident, Splenectomy
Clinical narrative: This 34 year-old male was involved in a sole vehicle helmeted motorcycle crash in which he suffered impact to his left side resulting in a grade V splenic laceration. Active splenic artery extravasation was managed with repeated arterial embolization by interventional radiology resulting in hemostasis but with large volume hemoperitoneum. Increasing pleural effusion with evidence of left hemothorax with adjacent atelectasis led to increasing oxygen requirements necessitating chest tube placement. In preparation for eventual discharge post-splenectomy vaccines were ordered and administered. Approximately 2 hours following administration, the patient became tachycardic with heart rate in the 170s and tachypneic to the 50s with a fall in oxygen saturation requiring O2 at up to 15 L/min. Severe rigors developed requiring treatment with meperidine and diphenhydramine. The patient was transferred to intensive care for ongoing management of hemothorax and video-assisted thoracoscopic surgery (VATS). Future vaccine administration to be managed by Allergy and Immunology.
Age: 34.0
Sex: M
Vaccine: MENB
Symptoms: Splenic artery embolisation, Splenic rupture, Tachycardia, Tachypnoea, Thoracic operation
Clinical narrative: This 34 year-old male was involved in a sole vehicle helmeted motorcycle crash in which he suffered impact to his left side resulting in a grade V splenic laceration. Active splenic artery extravasation was managed with repeated arterial embolization by interventional radiology resulting in hemostasis but with large volume hemoperitoneum. Increasing pleural effusion with evidence of left hemothorax with adjacent atelectasis led to increasing oxygen requirements necessitating chest tube placement. In preparation for eventual discharge post-splenectomy vaccines were ordered and administered. Approximately 2 hours following administration, the patient became tachycardic with heart rate in the 170s and tachypneic to the 50s with a fall in oxygen saturation requiring O2 at up to 15 L/min. Severe rigors developed requiring treatment with meperidine and diphenhydramine. The patient was transferred to intensive care for ongoing management of hemothorax and video-assisted thoracoscopic surgery (VATS). Future vaccine administration to be managed by Allergy and Immunology.
Age: 34.0
Sex: M
Vaccine: MENB
Symptoms: Thromboelastogram
Clinical narrative: This 34 year-old male was involved in a sole vehicle helmeted motorcycle crash in which he suffered impact to his left side resulting in a grade V splenic laceration. Active splenic artery extravasation was managed with repeated arterial embolization by interventional radiology resulting in hemostasis but with large volume hemoperitoneum. Increasing pleural effusion with evidence of left hemothorax with adjacent atelectasis led to increasing oxygen requirements necessitating chest tube placement. In preparation for eventual discharge post-splenectomy vaccines were ordered and administered. Approximately 2 hours following administration, the patient became tachycardic with heart rate in the 170s and tachypneic to the 50s with a fall in oxygen saturation requiring O2 at up to 15 L/min. Severe rigors developed requiring treatment with meperidine and diphenhydramine. The patient was transferred to intensive care for ongoing management of hemothorax and video-assisted thoracoscopic surgery (VATS). Future vaccine administration to be managed by Allergy and Immunology.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Headache, Oropharyngeal pain, Pyrexia
Clinical narrative: Breakthrough case. About 45 days after vaccine I started to have a bad headache, a sore throat with fever and chills. Took a Home COVID-19 test and it was positive. Had a telehealth appointment with a NP at the Hospital and was prescribed Paxlovid. Took full course and quarantined for 10 days. Started feeling better, didn't retest.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case. About 45 days after vaccine I started to have a bad headache, a sore throat with fever and chills. Took a Home COVID-19 test and it was positive. Had a telehealth appointment with a NP at the Hospital and was prescribed Paxlovid. Took full course and quarantined for 10 days. Started feeling better, didn't retest.
Age: 30.0
Sex: M
Vaccine: TDAP
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient was administered a Boostrix on 8/29/2022 that had expired on 8/19/2022.  Patient was immediately informed and was held for observation.  He had no adverse events and was offered a return visit for a fresh Tdap.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Dose 3 was given 4 weeks sooner than recommended interval
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient received Pfizer primary series #1 vaccination on 04/01/2021. This vaccination was Pfizer primary series #2 on 04/17/2021, which was 16 days later, not 21 days later.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Mobility decreased, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. I started feeling symptoms of a sore throat, difficulty getting out of the car due to feeling weak on 06/07/2022. On 06/10/22 I tested positive for COVID-19 via a home test. I called my doctor and we where referred to another doctor who was on-call. They prescribed PAXLOVID.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Acute respiratory failure, Anxiety, Blood glucose increased, COVID-19
Clinical narrative: Per Record: This patient was admitted to hospital on 8/11/2022 with 1 week of worsening of symptoms. Per record: Patient tested positive for COVID-19 on 8/5/2022 and was symptomatic of SOB, fever, chills, and increased anxiety since then. Per record this patient was Hypoxic on arrival with SpO2 78% on RA, improved to 96% on 6L O2 NC. Prior to the onset of symptoms patient had missed multiple dialysis sessions.  Per record, this patient was emergently dialyzed upon admission; shortness of breath worsened with hypoxia that was non-responsive to BiPAP.  Patient was intubated while in the ICU and also had an NSTEMI. After extubating patient has had periods of waxing and waning leukocytosis, and has also had multiple dialysis sessions. Ferritin 1117, procal 0.61. CXR shows fluid overload, R basilar opacity c/f atelectasis vs PNA. Patient was counseled about mortality benefits with steroids in COVID-related hypoxia, however she consistently declines this therapy. Per record, patient was afebrile, RR 22, 96% on 6L O2. No remdesivir per nephrology as patient is on hemodialysis. Per record, Pt was intubated on 08/12/2022 for acute hypoxic respiratory failure. Pt was noted to have rising troponin and evaluated by cardiology team with echocardiogram and plan was for an outpatient stress test. Patient received hemodialysis sessions as per nephrology recommendations. Pt was extubated on 0814/2022 and transitioned to bipap therapy. Pt was transferred to the floor on 08/20/2022 from the ICU. Code team was called just before 3:00 am. Upon arrival patient was sitting in the chair, unresponsive, with emergency protocol ongoing. Per record, this patient was noted to be in asystole initially and then was in V fib briefly for which patient was shocked and given 300m g IV amiodarone. Blood glucose level was greater than 200 gm/dl. Patient had significant yellowish secretions coming out of mouth and nose during ongoing CPR. Was intubated after placing NG tube during CPR. After approximately 18 minutes of CPR, there was no ROSC. Pt was pronounced dead on 8/25/22.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac arrest, Cardioversion, Chest X-ray abnormal, Chills, Condition aggravated
Clinical narrative: Per Record: This patient was admitted to hospital on 8/11/2022 with 1 week of worsening of symptoms. Per record: Patient tested positive for COVID-19 on 8/5/2022 and was symptomatic of SOB, fever, chills, and increased anxiety since then. Per record this patient was Hypoxic on arrival with SpO2 78% on RA, improved to 96% on 6L O2 NC. Prior to the onset of symptoms patient had missed multiple dialysis sessions.  Per record, this patient was emergently dialyzed upon admission; shortness of breath worsened with hypoxia that was non-responsive to BiPAP.  Patient was intubated while in the ICU and also had an NSTEMI. After extubating patient has had periods of waxing and waning leukocytosis, and has also had multiple dialysis sessions. Ferritin 1117, procal 0.61. CXR shows fluid overload, R basilar opacity c/f atelectasis vs PNA. Patient was counseled about mortality benefits with steroids in COVID-related hypoxia, however she consistently declines this therapy. Per record, patient was afebrile, RR 22, 96% on 6L O2. No remdesivir per nephrology as patient is on hemodialysis. Per record, Pt was intubated on 08/12/2022 for acute hypoxic respiratory failure. Pt was noted to have rising troponin and evaluated by cardiology team with echocardiogram and plan was for an outpatient stress test. Patient received hemodialysis sessions as per nephrology recommendations. Pt was extubated on 0814/2022 and transitioned to bipap therapy. Pt was transferred to the floor on 08/20/2022 from the ICU. Code team was called just before 3:00 am. Upon arrival patient was sitting in the chair, unresponsive, with emergency protocol ongoing. Per record, this patient was noted to be in asystole initially and then was in V fib briefly for which patient was shocked and given 300m g IV amiodarone. Blood glucose level was greater than 200 gm/dl. Patient had significant yellowish secretions coming out of mouth and nose during ongoing CPR. Was intubated after placing NG tube during CPR. After approximately 18 minutes of CPR, there was no ROSC. Pt was pronounced dead on 8/25/22.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Echocardiogram, Electrocardiogram, Endotracheal intubation
Clinical narrative: Per Record: This patient was admitted to hospital on 8/11/2022 with 1 week of worsening of symptoms. Per record: Patient tested positive for COVID-19 on 8/5/2022 and was symptomatic of SOB, fever, chills, and increased anxiety since then. Per record this patient was Hypoxic on arrival with SpO2 78% on RA, improved to 96% on 6L O2 NC. Prior to the onset of symptoms patient had missed multiple dialysis sessions.  Per record, this patient was emergently dialyzed upon admission; shortness of breath worsened with hypoxia that was non-responsive to BiPAP.  Patient was intubated while in the ICU and also had an NSTEMI. After extubating patient has had periods of waxing and waning leukocytosis, and has also had multiple dialysis sessions. Ferritin 1117, procal 0.61. CXR shows fluid overload, R basilar opacity c/f atelectasis vs PNA. Patient was counseled about mortality benefits with steroids in COVID-related hypoxia, however she consistently declines this therapy. Per record, patient was afebrile, RR 22, 96% on 6L O2. No remdesivir per nephrology as patient is on hemodialysis. Per record, Pt was intubated on 08/12/2022 for acute hypoxic respiratory failure. Pt was noted to have rising troponin and evaluated by cardiology team with echocardiogram and plan was for an outpatient stress test. Patient received hemodialysis sessions as per nephrology recommendations. Pt was extubated on 0814/2022 and transitioned to bipap therapy. Pt was transferred to the floor on 08/20/2022 from the ICU. Code team was called just before 3:00 am. Upon arrival patient was sitting in the chair, unresponsive, with emergency protocol ongoing. Per record, this patient was noted to be in asystole initially and then was in V fib briefly for which patient was shocked and given 300m g IV amiodarone. Blood glucose level was greater than 200 gm/dl. Patient had significant yellowish secretions coming out of mouth and nose during ongoing CPR. Was intubated after placing NG tube during CPR. After approximately 18 minutes of CPR, there was no ROSC. Pt was pronounced dead on 8/25/22.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrointestinal tube insertion, Haemodialysis, Hypervolaemia, Hypoxia, Inappropriate schedule of product administration
Clinical narrative: Per Record: This patient was admitted to hospital on 8/11/2022 with 1 week of worsening of symptoms. Per record: Patient tested positive for COVID-19 on 8/5/2022 and was symptomatic of SOB, fever, chills, and increased anxiety since then. Per record this patient was Hypoxic on arrival with SpO2 78% on RA, improved to 96% on 6L O2 NC. Prior to the onset of symptoms patient had missed multiple dialysis sessions.  Per record, this patient was emergently dialyzed upon admission; shortness of breath worsened with hypoxia that was non-responsive to BiPAP.  Patient was intubated while in the ICU and also had an NSTEMI. After extubating patient has had periods of waxing and waning leukocytosis, and has also had multiple dialysis sessions. Ferritin 1117, procal 0.61. CXR shows fluid overload, R basilar opacity c/f atelectasis vs PNA. Patient was counseled about mortality benefits with steroids in COVID-related hypoxia, however she consistently declines this therapy. Per record, patient was afebrile, RR 22, 96% on 6L O2. No remdesivir per nephrology as patient is on hemodialysis. Per record, Pt was intubated on 08/12/2022 for acute hypoxic respiratory failure. Pt was noted to have rising troponin and evaluated by cardiology team with echocardiogram and plan was for an outpatient stress test. Patient received hemodialysis sessions as per nephrology recommendations. Pt was extubated on 0814/2022 and transitioned to bipap therapy. Pt was transferred to the floor on 08/20/2022 from the ICU. Code team was called just before 3:00 am. Upon arrival patient was sitting in the chair, unresponsive, with emergency protocol ongoing. Per record, this patient was noted to be in asystole initially and then was in V fib briefly for which patient was shocked and given 300m g IV amiodarone. Blood glucose level was greater than 200 gm/dl. Patient had significant yellowish secretions coming out of mouth and nose during ongoing CPR. Was intubated after placing NG tube during CPR. After approximately 18 minutes of CPR, there was no ROSC. Pt was pronounced dead on 8/25/22.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Intensive care, Laboratory test abnormal, Leukocytosis, Lung opacity, Oral discharge
Clinical narrative: Per Record: This patient was admitted to hospital on 8/11/2022 with 1 week of worsening of symptoms. Per record: Patient tested positive for COVID-19 on 8/5/2022 and was symptomatic of SOB, fever, chills, and increased anxiety since then. Per record this patient was Hypoxic on arrival with SpO2 78% on RA, improved to 96% on 6L O2 NC. Prior to the onset of symptoms patient had missed multiple dialysis sessions.  Per record, this patient was emergently dialyzed upon admission; shortness of breath worsened with hypoxia that was non-responsive to BiPAP.  Patient was intubated while in the ICU and also had an NSTEMI. After extubating patient has had periods of waxing and waning leukocytosis, and has also had multiple dialysis sessions. Ferritin 1117, procal 0.61. CXR shows fluid overload, R basilar opacity c/f atelectasis vs PNA. Patient was counseled about mortality benefits with steroids in COVID-related hypoxia, however she consistently declines this therapy. Per record, patient was afebrile, RR 22, 96% on 6L O2. No remdesivir per nephrology as patient is on hemodialysis. Per record, Pt was intubated on 08/12/2022 for acute hypoxic respiratory failure. Pt was noted to have rising troponin and evaluated by cardiology team with echocardiogram and plan was for an outpatient stress test. Patient received hemodialysis sessions as per nephrology recommendations. Pt was extubated on 0814/2022 and transitioned to bipap therapy. Pt was transferred to the floor on 08/20/2022 from the ICU. Code team was called just before 3:00 am. Upon arrival patient was sitting in the chair, unresponsive, with emergency protocol ongoing. Per record, this patient was noted to be in asystole initially and then was in V fib briefly for which patient was shocked and given 300m g IV amiodarone. Blood glucose level was greater than 200 gm/dl. Patient had significant yellowish secretions coming out of mouth and nose during ongoing CPR. Was intubated after placing NG tube during CPR. After approximately 18 minutes of CPR, there was no ROSC. Pt was pronounced dead on 8/25/22.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Procalcitonin, Pyrexia, Resuscitation, Rhinorrhoea
Clinical narrative: Per Record: This patient was admitted to hospital on 8/11/2022 with 1 week of worsening of symptoms. Per record: Patient tested positive for COVID-19 on 8/5/2022 and was symptomatic of SOB, fever, chills, and increased anxiety since then. Per record this patient was Hypoxic on arrival with SpO2 78% on RA, improved to 96% on 6L O2 NC. Prior to the onset of symptoms patient had missed multiple dialysis sessions.  Per record, this patient was emergently dialyzed upon admission; shortness of breath worsened with hypoxia that was non-responsive to BiPAP.  Patient was intubated while in the ICU and also had an NSTEMI. After extubating patient has had periods of waxing and waning leukocytosis, and has also had multiple dialysis sessions. Ferritin 1117, procal 0.61. CXR shows fluid overload, R basilar opacity c/f atelectasis vs PNA. Patient was counseled about mortality benefits with steroids in COVID-related hypoxia, however she consistently declines this therapy. Per record, patient was afebrile, RR 22, 96% on 6L O2. No remdesivir per nephrology as patient is on hemodialysis. Per record, Pt was intubated on 08/12/2022 for acute hypoxic respiratory failure. Pt was noted to have rising troponin and evaluated by cardiology team with echocardiogram and plan was for an outpatient stress test. Patient received hemodialysis sessions as per nephrology recommendations. Pt was extubated on 0814/2022 and transitioned to bipap therapy. Pt was transferred to the floor on 08/20/2022 from the ICU. Code team was called just before 3:00 am. Upon arrival patient was sitting in the chair, unresponsive, with emergency protocol ongoing. Per record, this patient was noted to be in asystole initially and then was in V fib briefly for which patient was shocked and given 300m g IV amiodarone. Blood glucose level was greater than 200 gm/dl. Patient had significant yellowish secretions coming out of mouth and nose during ongoing CPR. Was intubated after placing NG tube during CPR. After approximately 18 minutes of CPR, there was no ROSC. Pt was pronounced dead on 8/25/22.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin increased, Swallow study, Troponin increased, Unresponsive to stimuli
Clinical narrative: Per Record: This patient was admitted to hospital on 8/11/2022 with 1 week of worsening of symptoms. Per record: Patient tested positive for COVID-19 on 8/5/2022 and was symptomatic of SOB, fever, chills, and increased anxiety since then. Per record this patient was Hypoxic on arrival with SpO2 78% on RA, improved to 96% on 6L O2 NC. Prior to the onset of symptoms patient had missed multiple dialysis sessions.  Per record, this patient was emergently dialyzed upon admission; shortness of breath worsened with hypoxia that was non-responsive to BiPAP.  Patient was intubated while in the ICU and also had an NSTEMI. After extubating patient has had periods of waxing and waning leukocytosis, and has also had multiple dialysis sessions. Ferritin 1117, procal 0.61. CXR shows fluid overload, R basilar opacity c/f atelectasis vs PNA. Patient was counseled about mortality benefits with steroids in COVID-related hypoxia, however she consistently declines this therapy. Per record, patient was afebrile, RR 22, 96% on 6L O2. No remdesivir per nephrology as patient is on hemodialysis. Per record, Pt was intubated on 08/12/2022 for acute hypoxic respiratory failure. Pt was noted to have rising troponin and evaluated by cardiology team with echocardiogram and plan was for an outpatient stress test. Patient received hemodialysis sessions as per nephrology recommendations. Pt was extubated on 0814/2022 and transitioned to bipap therapy. Pt was transferred to the floor on 08/20/2022 from the ICU. Code team was called just before 3:00 am. Upon arrival patient was sitting in the chair, unresponsive, with emergency protocol ongoing. Per record, this patient was noted to be in asystole initially and then was in V fib briefly for which patient was shocked and given 300m g IV amiodarone. Blood glucose level was greater than 200 gm/dl. Patient had significant yellowish secretions coming out of mouth and nose during ongoing CPR. Was intubated after placing NG tube during CPR. After approximately 18 minutes of CPR, there was no ROSC. Pt was pronounced dead on 8/25/22.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Ventricular fibrillation
Clinical narrative: Per Record: This patient was admitted to hospital on 8/11/2022 with 1 week of worsening of symptoms. Per record: Patient tested positive for COVID-19 on 8/5/2022 and was symptomatic of SOB, fever, chills, and increased anxiety since then. Per record this patient was Hypoxic on arrival with SpO2 78% on RA, improved to 96% on 6L O2 NC. Prior to the onset of symptoms patient had missed multiple dialysis sessions.  Per record, this patient was emergently dialyzed upon admission; shortness of breath worsened with hypoxia that was non-responsive to BiPAP.  Patient was intubated while in the ICU and also had an NSTEMI. After extubating patient has had periods of waxing and waning leukocytosis, and has also had multiple dialysis sessions. Ferritin 1117, procal 0.61. CXR shows fluid overload, R basilar opacity c/f atelectasis vs PNA. Patient was counseled about mortality benefits with steroids in COVID-related hypoxia, however she consistently declines this therapy. Per record, patient was afebrile, RR 22, 96% on 6L O2. No remdesivir per nephrology as patient is on hemodialysis. Per record, Pt was intubated on 08/12/2022 for acute hypoxic respiratory failure. Pt was noted to have rising troponin and evaluated by cardiology team with echocardiogram and plan was for an outpatient stress test. Patient received hemodialysis sessions as per nephrology recommendations. Pt was extubated on 0814/2022 and transitioned to bipap therapy. Pt was transferred to the floor on 08/20/2022 from the ICU. Code team was called just before 3:00 am. Upon arrival patient was sitting in the chair, unresponsive, with emergency protocol ongoing. Per record, this patient was noted to be in asystole initially and then was in V fib briefly for which patient was shocked and given 300m g IV amiodarone. Blood glucose level was greater than 200 gm/dl. Patient had significant yellowish secretions coming out of mouth and nose during ongoing CPR. Was intubated after placing NG tube during CPR. After approximately 18 minutes of CPR, there was no ROSC. Pt was pronounced dead on 8/25/22.
Age: 57.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Rash, Rash papular
Clinical narrative: Rash on trunk, chest and back. non pruritic. slightly raised. Rash onset approx 48 hrs after vaccinated. No fever or myalgias.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac arrest, Cardiogenic shock, Cardiovascular insufficiency, Catheterisation cardiac
Clinical narrative: 2/25/22 patient brought to ED by wife in car with CP, SOB, diaphoresis; became unresponsive in parking lot with cardiac arrest; CPR/ACLS with ROSC; patient in ED experienced another cardiac arrest; CPR/ACLS performed with success; to cath. lab; showed occlusion of proximal RCA with sluggish coronary flow through collaterals; experienced cardiogenic shock; intra-aortic balloon pump placed; found to be positive for COVID (no mention of treatment for COVID in medical records); 2/28/22 MRI of brain showed global ischemia; grim prognosis; patient transitioned to comfort measures; patient extubated and he passed away in the hospital.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral ischaemia, Chest pain, Coronary artery occlusion, Death, Dyspnoea
Clinical narrative: 2/25/22 patient brought to ED by wife in car with CP, SOB, diaphoresis; became unresponsive in parking lot with cardiac arrest; CPR/ACLS with ROSC; patient in ED experienced another cardiac arrest; CPR/ACLS performed with success; to cath. lab; showed occlusion of proximal RCA with sluggish coronary flow through collaterals; experienced cardiogenic shock; intra-aortic balloon pump placed; found to be positive for COVID (no mention of treatment for COVID in medical records); 2/28/22 MRI of brain showed global ischemia; grim prognosis; patient transitioned to comfort measures; patient extubated and he passed away in the hospital.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, Hyperhidrosis, Intra-aortic balloon placement, Life support, Magnetic resonance imaging head abnormal
Clinical narrative: 2/25/22 patient brought to ED by wife in car with CP, SOB, diaphoresis; became unresponsive in parking lot with cardiac arrest; CPR/ACLS with ROSC; patient in ED experienced another cardiac arrest; CPR/ACLS performed with success; to cath. lab; showed occlusion of proximal RCA with sluggish coronary flow through collaterals; experienced cardiogenic shock; intra-aortic balloon pump placed; found to be positive for COVID (no mention of treatment for COVID in medical records); 2/28/22 MRI of brain showed global ischemia; grim prognosis; patient transitioned to comfort measures; patient extubated and he passed away in the hospital.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Resuscitation, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: 2/25/22 patient brought to ED by wife in car with CP, SOB, diaphoresis; became unresponsive in parking lot with cardiac arrest; CPR/ACLS with ROSC; patient in ED experienced another cardiac arrest; CPR/ACLS performed with success; to cath. lab; showed occlusion of proximal RCA with sluggish coronary flow through collaterals; experienced cardiogenic shock; intra-aortic balloon pump placed; found to be positive for COVID (no mention of treatment for COVID in medical records); 2/28/22 MRI of brain showed global ischemia; grim prognosis; patient transitioned to comfort measures; patient extubated and he passed away in the hospital.
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient received COVID vaccine Pfizer booster (approved for 12 years and older) Lot #FP7139 on left deltoid at 12:30 pm, administered by LVN. Approximately one minute after vaccine administration, LVN noticed she had administered the incorrect COVID-19 Pfizer vaccine type, she noticed client was 11 years and 5 months of age. Healthcare staff submitted a medical consult to inform MD of vaccine error and current CDC recommendations. Father was informed by PHN of vaccine error and recommendation from MD, father denied any allergies, chronic medical conditions, or medications for patient. Patient denied experiencing any adverse reactions at the time of assessment, no additional interventions performed. The patient did not report any adverse events during the 30-minute observation period.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Anxiety, Blood test, Fatigue, Headache
Clinical narrative: Fatigue headaches hair loss anixety  weight loss
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, Weight decreased
Clinical narrative: Fatigue headaches hair loss anixety  weight loss
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given COVID vaccine 5-11 and he is 4 years and 10 months old. No side effects and/or symptoms.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Headache, Heart rate irregular, Pyrexia
Clinical narrative: I had fever and headache for 2 days and I'm still tired with irregular heart beats. I'm taking PAXLOVID.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had fever and headache for 2 days and I'm still tired with irregular heart beats. I'm taking PAXLOVID.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count abnormal, Platelet count decreased
Clinical narrative: Low platelets
Age: 39.0
Sex: M
Vaccine: UNK
Symptoms: Injection site pruritus, Injection site reaction, Injection site swelling, Skin lesion
Clinical narrative: After receiving the vaccine the morning of 8/29/22, the patient awoke on 8/30/22 and noticed a large bump at the injection site; the patient presented to the clinic in the afternoon as a walk-in. Upon inspection, the injection site had swollen into a round, uniform lesion measuring approximately 6-7 cm in diameter and raised approximately 0.5-1 cm above the patient's normal skin level. The lesion is firm, round, and uniform with distinct boundaries, mildly erythematous, and warm to touch. The patient reports that the lesion is nontender, nonpainful, and mildly pruritic. The patient denies all other symptoms, including shortness of breath, chest pain/tightness, rash, fever, headache, nausea, vomiting, diarrhea, and other local and systemic signs/symptoms.  The patient was assessed by MD. Dr. recommended that the patient continue to monitor the symptoms and apply a cold compress to the site twice a day for 15 minutes at a time until the lesion begins to dissipate. The nurse discussed other signs and symptoms that the patient should monitor for, and when the patient should get back in contact with the clinic and/or seek emergency medical attention. The patient verbalized understanding the plan and had no further questions or concerns.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Patient expired 8/29/2022.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaemia, Cold type haemolytic anaemia, Condition aggravated, Full blood count, Haptoglobin
Clinical narrative: Anemia worsening of cold agglutinin disease with more agglutination
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Carpal tunnel syndrome, Electromyogram abnormal, Hypoaesthesia, Muscular weakness, Pain in extremity
Clinical narrative: I was diagnosed with carpal tunnel syndrome on 12/31/2021. They wanted me to try sulfa salinize but I had side effects from that drug and discontinued use after 90 days. Both of my hands fall asleep during the day at night. It's very painful and tingly. I was dropping things and have weakness in my hands. My hands go numb when I drive or even when I'm not doing anything. They put me on methotrexate 30 days ago. It has been helping so far but I won't know the full effects until 90 days of taking the medication.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: I was diagnosed with carpal tunnel syndrome on 12/31/2021. They wanted me to try sulfa salinize but I had side effects from that drug and discontinued use after 90 days. Both of my hands fall asleep during the day at night. It's very painful and tingly. I was dropping things and have weakness in my hands. My hands go numb when I drive or even when I'm not doing anything. They put me on methotrexate 30 days ago. It has been helping so far but I won't know the full effects until 90 days of taking the medication.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Decreased appetite, Fatigue, Nausea, SARS-CoV-2 test positive
Clinical narrative: Pt admitted to Hospital for issues other than +Covid. Fatigue, exhaustion, and loss of appetite. Intermittent nausea w/out vomiting.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Pt admitted to Hospital for issues other than +Covid. Fatigue, exhaustion, and loss of appetite. Intermittent nausea w/out vomiting.
Age: 7.0
Sex: M
Vaccine: DTAP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Dtap Infanrix was given at a pt that was 7yrs 9mo old. Needed to recieve the TDap Boostrix.  Per physician pt had no adverse reaction will come in and get the TDap at 11y/o.